-
Omeros Spikes 37% Amid Favorable Medicare Policy In Congressional Spending Bill
Thursday, March 22, 2018 - 8:07am | 300Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company that mostly focuses on developing therapies for the treatment of complement-mediated diseases and disorders of the central nervous system, saw its stock soar nearly 40 percent Thursday morning. What Happened American...